Q: For approximately a decade, I have been taking trospium for incontinence. I would like to know if long-term usage of it could have an effect on dementia. I’ve heard about it often. Also, a 20-mg ...

Panelists discuss how the muscarinic pathway of xanomeline/trospium offers a safer, nondopaminergic approach to schizophrenia care. Panelists discuss how xanomeline/trospium chloride introduces a ...

Take on empty stomach. 20mg twice daily. ≥75yrs: 20mg once daily if twice daily dose not tolerated. Severe renal impairment (CrCl<30mL/min): 20mg once daily at bedtime. Bladder outflow obstruction. GI ...

Xanomeline-trospium (KarXT) — a novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent — led to statistically significant and clinically meaningful improvements in ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...

Panelists discuss how integrating xanomeline/trospium into clinical practice may expand safe and effective treatment options. Panelists discuss how clinicians are beginning to integrate ...

If you or someone you love has been diagnosed with schizophrenia, you probably know how difficult it can be to find a treatment that truly works—and one that doesn't cause frustrating or even painful ...